Globalization of the Indian Pharmaceutical Industry: Implications for Innovation
AbstractIn this article we create an industry-wide metrics of innovation based on the characterization of learning potential of foreign direct invest-ment (FDI), technology acquisition and in-house R&D, analysis of patenting activity, assessment of R&D directions and evaluation of innovation outcomes. Our purpose is to reflect on strategies adopted for learning, competence building and innovation and for creating complementarities and linkages within India’s pharmaceutical industry during the post- Trade Related Intellectual Property Rights (TRIPs) period. With India facing the challenge of constituting pathways and strategies for accelerated learning, we also explore through whose actions, types of strategies and routes of growth have the limits of Indian pharmaceutical industry innovation been reached within one decade. Finally, how and with what kind of policy design can the Indian state and society intervene to push the frontier of innovation further within this industry. Indian state and business have chosen globalization pathways with specific implications for innovation. We assess systemic connections of these implications, suggesting that for a significant change in domestic and foreign pharmaceutical firms’ orientation to disease, as reflected in outcomes of their R&D investment activity, there also has to be a major focus on pathways toward innovation for domestic markets.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Faculty of Economics and Administration, University of Malaya in its journal International Journal of Institutions and Economies.
Volume (Year): 3 (2011)
Issue (Month): 2 (July)
- globalization; innovation; learning; pathways; pharmaceuticals;
Find related papers by JEL classification:
- O32 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Management of Technological Innovation and R&D
- O33 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Technological Change: Choices and Consequences; Diffusion Processes
- O34 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
- O38 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Government Policy
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Athreye, Suma & Kale, Dinar & Ramani, Shyama V., 2008.
"Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector,"
MERIT Working Papers
041, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Suma Athreye & Dinar Kale & Shyama V. Ramani, 2009. "Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector," Industrial and Corporate Change, Oxford University Press, vol. 18(4), pages 729-759, August.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Professor Dr. Rajah Rasiah).
If references are entirely missing, you can add them using this form.